Literature DB >> 22113934

An empirical phase diagram approach to investigate conformational stability of "second-generation" functional mutants of acidic fibroblast growth factor-1.

Mohammad A Alsenaidy1, Tingting Wang, Jae Hyun Kim, Sangeeta B Joshi, Jihun Lee, Michael Blaber, David B Volkin, C Russell Middaugh.   

Abstract

Acidic fibroblast growth factor-1 (FGF-1) is an angiogenic protein which requires binding to a polyanion such as heparin for its mitogenic activity and physicochemical stability. To evaluate the extent to which this heparin dependence on solution stability could be reduced or eliminated, the structural integrity and conformational stability of 10 selected FGF-1 mutants were examined as a function of solution pH and temperature by a series of spectroscopic methods including circular dichroism, intrinsic and extrinsic fluorescence spectroscopy and static light scattering. The biophysical data were summarized in the form of colored empirical phase diagrams (EPDs). FGF-1 mutants were identified with stability profiles in the absence of heparin comparable to that of wild-type FGF-1 in the presence of heparin while still retaining their biological activity. In addition, a revised version of the EPD methodology was found to provide an information rich, high throughput approach to compare the effects of mutations on the overall conformational stability of proteins in terms of their response to environmental stresses such as pH and temperature.
Copyright © 2011 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22113934      PMCID: PMC3375442          DOI: 10.1002/pro.2008

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  41 in total

1.  Symmetric primary and tertiary structure mutations within a symmetric superfold: a solution, not a constraint, to achieve a foldable polypeptide.

Authors:  Stephen R Brych; Vikash K Dubey; Ewa Bienkiewicz; Jihun Lee; Timothy M Logan; Michael Blaber
Journal:  J Mol Biol       Date:  2004-11-26       Impact factor: 5.469

2.  Characterizing biological products and assessing comparability following manufacturing changes.

Authors:  Arthur J Chirino; Anthony Mire-Sluis
Journal:  Nat Biotechnol       Date:  2004-11       Impact factor: 54.908

3.  Comparability is not just analytical equivalence.

Authors:  Anthony S Lubiniecki; M Marcia Federici
Journal:  Biologicals       Date:  2005-12-02       Impact factor: 1.856

4.  X-ray crystal structure of human acidic fibroblast growth factor.

Authors:  M Blaber; J DiSalvo; K A Thomas
Journal:  Biochemistry       Date:  1996-02-20       Impact factor: 3.162

5.  Effect of low pH and heparin on the structure of acidic fibroblast growth factor.

Authors:  A Pineda-Lucena; I Núñez De Castro; R M Lozano; I Muñoz-Willery; M Zazo; G Giménez-Gallego
Journal:  Eur J Biochem       Date:  1994-06-01

6.  Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease.

Authors:  B Schumacher; P Pecher; B U von Specht; T Stegmann
Journal:  Circulation       Date:  1998-02-24       Impact factor: 29.690

7.  1-Anilino-8-naphthalene sulfonate anion-protein binding depends primarily on ion pair formation.

Authors:  D Matulis; R Lovrien
Journal:  Biophys J       Date:  1998-01       Impact factor: 4.033

8.  Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.

Authors:  Amartya Basu; Karen Yang; Maoliang Wang; Sam Liu; Ramesh Chintala; Thomas Palm; Hong Zhao; Ping Peng; Dechun Wu; Zhenfan Zhang; Jack Hua; Ming-Ching Hsieh; John Zhou; Gerald Petti; Xiguang Li; Ahsen Janjua; Magda Mendez; Jun Liu; Clifford Longley; Zhihua Zhang; Mary Mehlig; Virna Borowski; Manickam Viswanathan; David Filpula
Journal:  Bioconjug Chem       Date:  2006 May-Jun       Impact factor: 4.774

9.  Effects of solutes on empirical phase diagrams of human fibroblast growth factor 1.

Authors:  Haihong Fan; Huaina Li; Mingyu Zhang; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2007-06       Impact factor: 3.534

10.  A branched monomethoxypoly(ethylene glycol) for protein modification.

Authors:  C Monfardini; O Schiavon; P Caliceti; M Morpurgo; J M Harris; F M Veronese
Journal:  Bioconjug Chem       Date:  1995 Jan-Feb       Impact factor: 4.774

View more
  12 in total

1.  Improved data visualization techniques for analyzing macromolecule structural changes.

Authors:  Jae Hyun Kim; Vidyashankara Iyer; Sangeeta B Joshi; David B Volkin; C Russell Middaugh
Journal:  Protein Sci       Date:  2012-09-17       Impact factor: 6.725

Review 2.  Emergence of symmetric protein architecture from a simple peptide motif: evolutionary models.

Authors:  Michael Blaber; Jihun Lee; Liam Longo
Journal:  Cell Mol Life Sci       Date:  2012-07-13       Impact factor: 9.261

3.  High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation.

Authors:  Mohammad A Alsenaidy; Jae Hyun Kim; Ranajoy Majumdar; David D Weis; Sangeeta B Joshi; Thomas J Tolbert; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2013-09-24       Impact factor: 3.534

4.  Probing structurally altered and aggregated states of therapeutically relevant proteins using GroEL coupled to bio-layer interferometry.

Authors:  Subhashchandra Naik; Ozan S Kumru; Melissa Cullom; Srivalli N Telikepalli; Elizabeth Lindboe; Taylor L Roop; Sangeeta B Joshi; Divya Amin; Phillip Gao; C Russell Middaugh; David B Volkin; Mark T Fisher
Journal:  Protein Sci       Date:  2014-07-28       Impact factor: 6.725

5.  Commentary: current perspectives on the aggregation of protein drugs.

Authors:  Elizabeth M Topp
Journal:  AAPS J       Date:  2014-02-22       Impact factor: 4.009

6.  A single aromatic core mutation converts a designed "primitive" protein from halophile to mesophile folding.

Authors:  Liam M Longo; Connie A Tenorio; Ozan S Kumru; C Russell Middaugh; Michael Blaber
Journal:  Protein Sci       Date:  2014-10-25       Impact factor: 6.725

7.  Physical stability comparisons of IgG1-Fc variants: effects of N-glycosylation site occupancy and Asp/Gln residues at site Asn 297.

Authors:  Mohammad A Alsenaidy; Solomon Z Okbazghi; Jae Hyun Kim; Sangeeta B Joshi; C Russell Middaugh; Thomas J Tolbert; David B Volkin
Journal:  J Pharm Sci       Date:  2014-04-16       Impact factor: 3.534

8.  Folding nucleus structure persists in thermally-aggregated FGF-1.

Authors:  Liam M Longo; Yuan Gao; Connie A Tenorio; Gan Wang; Anant K Paravastu; Michael Blaber
Journal:  Protein Sci       Date:  2017-11-21       Impact factor: 6.725

9.  The ubiquitous buried water in the beta-trefoil architecture contributes to the folding nucleus and ~20% of the folding enthalpy.

Authors:  Joseph B Parker; Connie A Tenorio; Michael Blaber
Journal:  Protein Sci       Date:  2021-10-06       Impact factor: 6.725

10.  Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application.

Authors:  Xue Xia; Joseph P Babcock; Sachiko I Blaber; Kathleen M Harper; Michael Blaber
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.